Second malignant neoplasms in operable carcinoma of the breast.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008408:Mastectomy; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced* / Q000188:drug therapy; D011183:Postoperative Complications / Q000188:drug therapy; D011379:Prognosis; D012306:Risk